OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis, characterization, cytotoxic evaluation, and molecular docking studies of novel 1,2,3-triazole-based chalcones for potential anticancer applications
Venkateswarlu Banoji, A. Kishore Kumar, V. Sunitha, et al.
Results in Chemistry (2023) Vol. 7, pp. 101294-101294
Open Access | Times Cited: 9

Showing 9 citing articles:

Therapeutic potential of chalcone-1,2,3-triazole hybrids as anti-tumour agents: a systematic review and SAR studies
Sakshi Priya, Md. Shafiqul Islam, Shivani Kasana, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 4, pp. 449-465
Closed Access

Pharmacological Significance of 1,2,3-Triazoles
Mubarak H. Shaikh, Amol A. Nagargoje, Dattatraya N. Pansare, et al.
Advances in chemical and materials engineering book series (2025), pp. 155-202
Closed Access

The current landscape of 1,2,3‐triazole hybrids with anticancer therapeutic potential: Part I
Shanshan Huang, Zhi Xu, Yafei Zhuang
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Closed Access

Microwave-assisted Click Synthesis, Characterisation, and In silico Studies of novel 2H-chromene-1,2,3-triazolyl glycoconjugates as Potent Anticancer and Antibacterial agents
Bhabani Shankar Panda, Mohammed Ansar Ahemad, Suhasini Mohapatra, et al.
Journal of Molecular Structure (2024) Vol. 1318, pp. 139323-139323
Closed Access | Times Cited: 3

Synthesis of Novel (R)-Carvone-1,2,3-Triazole Hybrids: Network Pharmacology, Molecular Docking, and Dynamics Simulation Targeting Tumor Protein Markers
Abdoullah Bimoussa, Yassine Laamari, Mourad Fawzi, et al.
Journal of Molecular Structure (2024), pp. 140489-140489
Closed Access | Times Cited: 3

Advances in chalcone-based anticancer therapy: mechanisms, preclinical advances, and future perspectives
Shefali Chowdhary, Preeti Preeti, Shekhar Shekhar, et al.
Expert Opinion on Drug Discovery (2024)
Closed Access | Times Cited: 1

Utilizing perhalopyridine-based alkynes as suitable precursors for the synthesis of novel poly(1,2,3-triazolyl)-substituted perhalopyridines
Fereshteh Khorasani, Reza Ranjbar‐Karimi, Kazem Mohammadiannejad
RSC Advances (2024) Vol. 14, Iss. 42, pp. 30873-30885
Open Access

Rational design, synthesis and anticancer screening of 1,2,4-oxadiazole incorporated thieno[2,3-d]thiazole-isoxazole-pyridine derivatives
Rambabu Vasamsetti, Naresh Babu Gatchakayala, Pawan Kumar, et al.
Results in Chemistry (2024), pp. 101823-101823
Open Access

Uncovering the Potential of Chalcone‐Sulfonamide Hybrids: A Systematic Review on Their Anticancer Activity and Mechanisms of Action
Jéssica Maria Teles Souza, Stéphanie Aguiar de Negreiros Matos Silva, Rebeca Barbosa da Rocha, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 7
Open Access

Page 1

Scroll to top